Irregular vaginal bleeding with etonorgestrel contraceptive implant: a pilot randomised controlled trial of prophylactic down regulation with a gonadotrophin releasing hormone analogue [triptorelin] prior to implant insertion
Phase of Trial: Phase IV
Latest Information Update: 11 May 2016
At a glance
- Drugs Triptorelin (Primary)
- Indications Vaginal bleeding
- Focus Therapeutic Use
- 31 Dec 2009 Status changed from unconfirmed to completed as reported by ISRCTN: Current Controlled Trials record.
- 27 Aug 2008 New trial record.